2021
STOCKHOLDER INFORMATION

The secure way to view our annual documents and vote your shares.

Investor Materials

View enhanced versions of our annual documents below.

2020 Annual Report

2021 Proxy Statement

Request Paper Materials

You may request paper copies of the above annual documents online, by email or by phone by dialing 866-648-8133.

Voting

Your vote is IMPORTANT!

Please be sure to vote your proxy.  You may vote online or by phone by dialing 866-858-9151.

Virtual Meeting Details

DATE:
August 18, 2021

TIME:
1:00 PM PT


DEADLINE TO REGISTER:
August 16, 2021 - 5:00 PM ET

Note: You must register by the deadline to be eligible to participate in the meeting.

About Us

HTG Molecular Diagnostics, Inc.'s mission is to empower precision medicine at the local level. The company’s proprietary HTG EdgeSeq technology automates multiplexed molecular profiling of nucleic acids in a wide variety of solid and liquid samples, even when very limited in amount. The extraction free workflow paired with detection by next-generation sequencing offers many advantages and enables meaningful applications, such as identifying biomarkers important for precision medicine, understanding the clinical relevance of these biomarkers, and, ultimately, identifying treatment options.

Powered by Donnelley Financial Solutions
Copyright © 2021 Mediant Communications Inc. All Rights Reserved